Durgam Suresh K.'s Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Jan 4, 2024
- Accession no.
- 0000950170-24-002240
- Filed
- Jan 4, 2024
- Trade date
- Jan 2, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.40M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Durgam Suresh K.CIK 0001829958 | Officer (EVP, Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Common Stock | MOption exerciseAcquired | +62,282 | $19.87 | +$1,237,543.34 | 62,282 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −37,427 | $70.41 | −$2,635,235.07 | 24,855 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −22,645 | $70.80 | −$1,603,266 | 2,210 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −2,210 | $71.77 | −$158,611.7 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Common Stock | MOption exerciseDisposed | −62,282 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.